Patient-Centered Healthcare Analytics
As healthcare organizations face mounting pressures to improve health outcomes and demonstrate value, they’re increasingly relying on patient-level analytics to drive better decision-making.
These insights enable healthcare stakeholders to assess the value of medicines and treatments, identify underserved populations, understand treatment variability and guide key business decisions.
Our global program of patient-centered analytics and services—IMS LifeLink™—represents a holistic view of the patient, including drug utilization, disease management and treatment decisions. Leveraging leading sources of de-identified patient data and advanced technology tools, we help our clients operate with a common, patient-based view of their business.
By uniquely connecting patient, prescriber and payer dynamics, you can understand critical interrelationships and influences across the healthcare continuum. This knowledge informs mission-critical commercial decisions and enables providers and consumers to make more informed healthcare choices.
Key Application Groups
News
IMS’s acquisition of SDI greatly enhances our portfolio, extending our therapeutic coverage and bringing additional capabilities across a multitude of classes, channels and specialty issues.
Featured Offering
Formulary Impact Analyzer (FIA)
IMS’s Formulary Impact Analyzer (FIA) measures the rate of plan-specific rejection and patient-based pharmacy reversals.
